Investors in big pharma, biotech look to ride out Trump storm

Investors in big pharma, biotech look to ride out Trump storm


Jan 12 Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of political uncertainty as the incoming Trump administration dives into healthcare policy. The sector took a pounding on Wednesday after U.S. president-elect Donald Trump said the drug industry was "getting away with murder" on medicine costs, suggesting that the specter of government actions on pricing is not going away any time soon.



from Biotech News